Delayed pressure urticaria: Response to treatment with sulfasalazine in a case series of seventeen patients

Dermatologic Therapy

Volumn 28, Issue 5, 2015, Pages 318-322

  Swerlick, Robert A ^a   Puar, Neha ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DAYANAND MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

pressure; sulfasalazine; therapy systemic; urticaria

Indexed keywords

DAPSONE; SALAZOSULFAPYRIDINE; CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; DELAYED PRESSURE URTICARIA; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; PATIENT REFERRAL; RETROSPECTIVE STUDY; SKIN BIOPSY; TREATMENT DURATION; TREATMENT RESPONSE; URTICARIA; VESICULAR RASH; BIOPSY; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; YOUNG ADULT;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SULFASALAZINE; TREATMENT OUTCOME; URTICARIA; YOUNG ADULT;

EID: 84943815839     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12266     Document Type: Article

References (29)

1. Lawlor F, Black AK., Delayed pressure urticaria. Immunol Allergy Clin North Am 2004; 24: 247-258, vi-vii.
2. Barlow RJ, Warburton F, Watson K, Black AK, Greaves MW., Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol 1993; 29: 954-958.
3. Poon E, Seed PT, Greaves MW, Kobza-Black A., The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999; 140: 667-671.
4. Kobza-Black A., Delayed pressure urticaria. J Invest Dermatol Symp Proc 2001; 6: 148-149.
5. Sussman GL, Harvey RP, Schocket AL., Delayed pressure urticaria. J Allergy Clin Immunol 1982; 70: 337-342.
6. Weedon D, Strutton G, Rubin AI, Weedon D., Weedon's skin pathology. Edinburgh: Churchill Livingstone/Elsevier, 2010; 1 online resource (1041 p.)
7. Davis KC, Mekori YA, Kohler PF, Schocket AL., Late cutaneous reactions in patients with delayed pressure urticaria. J Allergy Clin Immunol 1984; 73: 810-812.
8. Bukantz SC., Acute severe asthma-The late-phase reaction and the continuing challenge. Hosp Pract 1986; 21: 10, 15-16.
9. Charlesworth EN, Hood AF, Soter NA, et al., Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989; 83: 1519-1526.
10. Kaliner MA., The late-phase reaction and its clinical implications. Hosp Pract 1987; 22: 73-83.
11. Solley GO, Gleich GJ, Jordon RE, Schroeter AL., The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest 1976; 58: 408-420.
12. Dover JS, Black AK, Ward AM, Greaves MW., Delayed pressure urticaria. Clinical features, laboratory investigations, and response to therapy of 44 patients. J Am Acad Dermatol 1988; 18: 1289-1298.
13. Czarnetzki BM, Meentken J, Kolde G, Brocker EB., Morphology of the cellular infiltrate in delayed pressure urticaria. J Am Acad Dermatol 1985; 12: 253-259.
14. Winkelmann RK, Black AK, Dover J, Greaves MW., Pressure urticaria-histopathological study. Clin Exp Dermatol 1986; 11: 139-147.
15. Morioke S, Takahagi S, Iwamoto K, et al., Pressure challenge test and histopathological inspections for 17 Japanese cases with clinically diagnosed delayed pressure urticaria. Arch Dermatol Res 2010; 302: 613-617.
16. Cassano N, Mastrandrea V, Vestita M, Vena GA., An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment. Dermatol Ther 2009; 22 (Suppl 1): S22-26.
17. Kontou-Fili K, Maniatakou G, Demaka P, Gonianakis M, Paleologos G., Therapeutic effects of cetirizine in delayed pressure urticaria. Part 1. Effects on weight tests and skin-window cytology. Ann Allergy 1990; 65: 517-519.
18. Vena GA, Cassano N, D'Argento V, Milani M., Clobetasol propionate 0.05% in a novel foam formulation is safe and effective in the short-term treatment of patients with delayed pressure urticaria: a randomized, double-blind, placebo-controlled trial. Br J Dermatol 2006; 154: 353-356.
19. Dawn G, Urcelay M, Ah-Weng A, O'Neill SM, Douglas WS., Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria. Br J Dermatol 2003; 149: 836-840.
20. Hermes B, Prochazka AK, Haas N, et al., Upregulation of TNF-alpha and IL-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999; 103: 307-314.
21. Magerl M, Philipp S, Manasterski M, Friedrich M, Maurer M., Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol 2007; 119: 752-754.
22. Bindslev-Jensen C, Skov PS., Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010; 65: 138-139.
23. Rodriguez-Rodriguez M, Antolin-Amerigo D, Barbarroja-Escudero J, Sanchez-Gonzalez MJ, Alvarez-Mon M., Successful treatment of severe delayed pressure angio-oedema with omalizumab. Allergol Immunopathol 2014; 42: 78-80.
24. Engler RJ, Squire E, Benson P., Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy, Asthma Immunol 1995; 74: 155-159.
25. Hartmann K, Hani N, Hinrichs R, Hunzelmann N, Scharffetter-Kochanek K., Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria. Acta Derm Venereol 2001; 81: 71.
26. Grundmann SA, Kiefer S, Luger TA, Brehler R., Delayed pressure urticaria-dapsone heading for first-line therapy? J Dtsch Dermatol Ges 2011; 9: 908-912.
27. McGirt LY, Vasagar K, Gober LM, Saini SS, Beck LA., Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol 2006; 142: 1337-1342.
28. Orden RA, Timble H, Saini SS., Efficacy and safety of sulfasalazine in patients with chronic idiopathic urticaria. Ann Allergy, Asthma Immunol 2014; 112: 64-70.
29. Dodiuk-Gad RP, Laws PM, Shear NH., Epidemiology of severe drug hypersensitivity. Semin Cutan Med Surg 2014; 33: 2-9.